Compare McKesson Corporation (MCK) vs United Parcel Service Inc (UPS) Price & Performance

McKesson Corporation (MCK) trades at $938.84, up 3.13% with strong technical momentum and bullish analyst sentiment. The stock shows consistent earnings beats with Q2 2026 EPS of $9.93 exceeding expectations of $9.56. Recent news highlights the extension of McKesson's pharmaceutical distribution agreement with CVS Health through 2032, reinforcing long-term revenue visibility. Revenue growth remains robust, climbing from $264.0B in 2022 to $359.1B in 2025, though net margins are thin at 1.12%.

The outlook is positive with 81% analyst buy ratings and a $956.43 consensus price target. Key risks include margin pressure from drug pricing policies and high current liabilities of $61.60B. The stock's valuation at 24.95x P/E appears reasonable given earnings growth projections, but investors should monitor debt levels and regulatory developments in healthcare distribution.

UPS trades at $94.54, up 2.45% on the day, with a bearish technical signal but strong recent earnings beats. The stock shows a P/E of 17.5 and a 5.08% net income margin, with revenue declining to $88.66B in 2025. Analyst consensus is a Buy with a $118.67 price target, while recent news highlights margin pressures and new e-commerce initiatives like the UPS Secure Commerce platform.

The outlook is mixed: a high dividend yield near 7% and valuation support offer upside potential, but declining revenue, competitive threats from Amazon, and fuel cost headwinds pose risks. Earnings growth from cost-cutting and domestic margin improvement remains the key catalyst for stock performance.